Trademarkia Logo

Canada

C$
Trademark Search in Canada
SNIM

View On IC.GC.CA

SNIM
SEARCHED

on 6 Feb 2025

Last Applicant/ Owned by

Ethris GmbH

Semmelweisstr. 382152 Planegg

DE

Serial Number

2327302 filed on 21st Dec 2023

Correspondent Address

SMART & BIGGAR LP

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOTTAWA

ONTARIO

CA

K1P5Y6

SNIM

Trademark usage description

preservatives for pharmaceuticals; chemicals for use in industry and science; chemical substances for biological preparations regarding use in industr Read More

Classification Information

Class [001]
Preservatives for pharmaceuticals; chemicals for use in industry and science; chemical substances for biological preparations regarding use in industry and science; biological preparations for use in industry and science; nucleic acids and organic chemicals for use in industry and science; industrial organic chemicals; organic chemicals for the industry; detergents for use in manufacture and industry; salts for industrial purposes; chemical and organic compositions for use in the manufacture of food and beverages; aqueous chemical compositions; triglycerides; nucleic recombinant acids; nucleic acids; nucleic acids for scientific purposes; pyrimidine; lipids for use in manufacture; hydrosoluble polymers; polymer dispersions; biodegradable polymer compositions; hydrogel polymer coatings; cationic polymers; polymer solutions; aqueous polymer dispersions; fatty acid esters.

Classification kind code

12

Class [005]
Pharmaceuticals; pharmaceutical drugs; dermatological pharmaceutical products; pharmaceutical preparations; dermatological pharmaceutical substances; pharmaceutical compositions; antidiabetic pharmaceuticals; anti-diabetic pharmaceuticals; cardiovascular pharmaceuticals; injectable pharmaceuticals; tissue-regenerative pharmaceutical preparations; cardiovascular pharmaceutical preparations; antibacterial pharmaceuticals; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; anaesthetic preparations for inhalation; pharmaceutical preparations for inhalers; sanitary preparations and articles; hygienic preparations and articles; air deodorising and air purifying preparations; dental preparations; dental articles, namely materials for tooth restoration, dental cements, dental filling materials, bone fillers consisting of living materials as well as bone growth media consisting of biological materials for medical purposes; medicated dentifrices; dietary supplements and dietetic preparations; pest control preparations and articles; pharmaceutical preparations for the treatment of kidney diseases; respiratory stimulants; compounds for treating correlated pulmonary syndromes; medicines for the treatment of cardiovascular and cerebrovascular diseases; fertility enhancement preparations; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for the prevention of disorders of the immune system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the prevention of autoimmune disorders; autoantigens; vaccines; vaccine preparations; vaccine adjuvants; veterinary vaccines; vaccines against pneumococcal infections; viral vaccines; human vaccine preparations; vaccines against flu; oral vaccine preparations; antiviral drugs for treating influenza; vaccines for human use; fat emulsions for medical infusions; medical preparations; medicinal healthcare preparations; medicinal infusions; infusions (medicinal -); medicinal preparations and substances; medicine; serotherapeutic medicines; antiallergic medicines; medicines for animals; nucleic acid sequences for medical and veterinary purposes; acids for pharmaceutical purposes; adjuvants for medical purposes; cellular function activating agents for medical purposes; chemical preparations for medical purposes; chemical preparations for veterinary purposes; nasal sprays for medical purposes; medicated nasal spray preparations; pharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; compounds for treating cancer; pharmaceutical preparations for activating cellular function; vaccines for cattle; vaccines for horses; veterinary vaccines for bovine animals; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the prevention of inflammatory diseases; pharmaceutical preparations for the prevention of allergies; pharmaceutical preparations for the prevention of diseases of the cardio-vascular system; pharmaceutical preparations for the prevention of diseases of the musculo-skeletal system; pharmaceutical preparations for the prevention of diseases of the respiratory system; pharmaceutical preparations for the prevention of inflammatory disorders; pharmaceutical preparations for the prevention of diseases of the genitourinary system; pharmaceutical preparations for the prevention of diabetes; pharmaceutical preparations for the prevention of diseases caused by bacteria; pharmaceutical preparations for treating arthritis; medicated ointments for treating dermatological conditions; medicated lotions for treating dermatological conditions; medicated creams for treating dermatological conditions; pharmaceutical preparations for treating gastrointestinal disorders; pharmaceutical preparations for treating chloasma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations and substances; bronchodilating preparations; organotherapeutic preparations; chemico-pharmaceutical preparations.

Classification kind code

12

Class [042]
Research of pharmaceuticals; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; vaccine research and development services; research and development services relating to vaccines; development of gene-based medicines; gene therapy research; research in the field of gene therapy; laboratory research in the field of gene expression; research in the field of gene editing technology; research and development services in the field of gene expression systems; advisory services relating to gene therapy research; biotechnology research; research and development in the pharmaceutical and biotechnology fields; biotechnology testing; scientific research relating to biology; scientific research in the field of genetics and genetic engineering; animal genetics research; research relating to molecular sciences; information on the subject of scientific research in the field of biochemistry and biotechnology; scientific research in the field of genetics; scientific research relating to genetics.

Classification kind code

12

Class [044]
Preparation and dispensing of medications; fertility treatment; human fertility treatment services; vaccination services; regenerative medicine services; dispensing of pharmaceuticals; therapy services; medical treatment services.

Classification kind code

12

Mark Details

Serial Number

2327302

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 256
on 17th Mar 2025		Notification of Possible Opposition Sent
Submitted for opposition 22
on 6th Feb 2025		Search Recorded
Submitted for opposition 20
on 6th Feb 2025		Examiner's First Report
Submitted for opposition 223
on 6th Feb 2025		Total Provisional Refusal
Submitted for opposition 48
on 2th Jul 2024		Agent Changed
Submitted for opposition 257
on 16th May 2024		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 15th May 2024		Formalized
Submitted for opposition 1
on 15th May 2024		Created
Submitted for opposition 228
on 21st Dec 2023		International Registration
Submitted for opposition 30
on 21st Dec 2023		Filed